Sonoma Pharmaceuticals reports Q2 (59c) vs ($5.75) last year

Reports Q2 revenue $3.6M vs. $2.7M last year. “Our results this quarter reflect the diligent efforts by Sonoma’s team to grow our business and drive toward profitability,” said Amy Trombly, CEO of Sonoma. “Revenues were up 31%, our net loss improved by 59%, and we saw positive cash flows from our operations for the quarter. Additionally, we set the stage for future growth with a new partnership to distribute our wound care products in the U.S. and Canada, and received a new FDA clearance to strengthen the indications for our eye care and dermatological products.”